Palliative-care pain science • Description • Classification • Physiology • Emergency relevance

Description, Classification and Physiology of Pain

An exhaustive foundation for emergency medicine and palliative-care students

Learning objectives

By the end of this lesson, the learner should be able to:

• Define pain and distinguish it from nociception, suffering and pain behaviour.
• Explain the multidimensional and biopsychosocial nature of pain, including “total pain” in palliative care.
• Classify pain by duration, mechanism, anatomical source, pattern, severity and clinical context.
• Describe transduction, transmission, perception, modulation and the major ascending and descending pathways.
• Explain peripheral and central sensitization, hyperalgesia, allodynia and referred pain.
• Recognize mixed-mechanism pain and the limits of a single label.
• Connect physiology to bedside findings, communication, examination and emergency escalation.

1. What is pain?

The International Association for the Study of Pain (IASP) defines pain as an unpleasant sensory and emotional experience associated with, or resembling that associated with, actual or potential tissue damage. The definition intentionally includes both body signals and the person’s lived experience. Pain is real even when imaging, laboratory tests or visible injury do not explain its intensity.

Related concepts

Concept	Meaning	Clinical caution
Nociception	Detection and neural processing of noxious mechanical, thermal or chemical stimuli by nociceptors.	It is not synonymous with pain and cannot be measured directly by a pain score.
Suffering	Distress arising when a threat overwhelms a person’s coping, identity, meaning or relationships.	Pain relief alone may not relieve suffering if fear, isolation or spiritual distress persists.
Pain behaviour	Observable actions or communication such as guarding, grimacing, moaning, withdrawal or seeking help.	Behaviour may be absent despite severe pain or present for reasons other than pain.
Illness experience	The meaning a person gives to symptoms and how illness affects roles, work, family and future.	Ask the person what the pain means instead of assuming.
Total pain	Physical, psychological, social and spiritual dimensions of distress acting together.	Assess all four dimensions in palliative care.

2. Pain in palliative care: “total pain”

Palliative-care pain is not limited to tumour invasion or a surgical wound. A person may have several simultaneous pains: bone metastases, neuropathy from chemotherapy, constipation, pressure injury, panic, family conflict, financial insecurity and fear of dying. These dimensions amplify each other.

Dimension	Examples	Questions that reveal it
Physical	Tumour, inflammation, infection, fracture, neuropathy, treatment toxicity, immobility, constipation or urinary retention.	“Where is it? What does it feel like? What makes it better or worse?”
Psychological	Fear, anxiety, depression, trauma, uncertainty, loss of control and sleep deprivation.	“What worries you most about this pain?”
Social	Isolation, caregiver strain, stigma, unemployment, transport and medicine costs, unsafe housing or family conflict.	“How is the pain affecting your family, work, money and ability to obtain care?”
Spiritual/existential	Loss of meaning, guilt, hopelessness, anger at God, fear of death or disrupted religious practice.	“What gives you strength? Are there beliefs or concerns we should understand?”

3. Classification by duration and time course

Type	Typical description	Examples and implications
Acute pain	Recent-onset pain linked to injury, inflammation, procedure or illness; usually has a protective function and tends to resolve as the cause heals.	Fracture, burn, appendicitis, myocardial infarction, postoperative pain. A new acute pain in a palliative patient still requires urgent assessment.
Subacute pain	Pain persisting beyond the expected early phase but not yet meeting the usual definition of chronic pain.	Persistent pain after surgery or infection; reassess diagnosis, healing and risk of transition to persistent pain.
Chronic or persistent pain	Pain that continues or recurs beyond normal tissue healing, commonly defined as three months or more.	May involve sensitization, disability, sleep disturbance, mood changes and altered social roles. It can be primary, secondary or mixed.
Recurrent pain	Repeated episodes separated by periods of little or no pain.	Migraine, sickle-cell crises, episodic obstruction or recurrent procedures.
Incident pain	A predictable flare caused by an activity or procedure.	Turning, walking, dressing a wound, coughing or swallowing.
Breakthrough pain	A transient exacerbation occurring despite otherwise controlled baseline pain.	May be spontaneous or incident; document trigger, onset, peak, duration and response.
End-of-dose pain	Pain returning before the next scheduled dose of a regular analgesic.	Requires review of the cause, dosing interval, adherence, absorption and disease progression—not automatic dose escalation.

Duration is a guide, not a complete diagnosis. A patient can have chronic cancer pain with acute superimposed sepsis or fracture.

4. Classification by mechanism

Mechanism	Definition	Typical features	Examples
Nociceptive pain	Pain arising from actual or threatened damage to non-neural tissue with activation of nociceptors and a functioning somatosensory system.	Often aching, throbbing, cramping or sharp; usually linked to movement, inflammation or an identifiable tissue process.	Bone metastasis, arthritis, postoperative wound, fracture, inflammatory bowel disease.
Somatic nociceptive	From skin, muscle, bone, joints, fascia or connective tissue.	More localized; bone pain may be deep, aching or movement-related; skin pain may be sharp or burning.	Pressure injury, wound, pathological fracture, arthritis.
Visceral nociceptive	From internal organs, capsules or serosal surfaces.	Diffuse, poorly localized, squeezing, cramping or deep; may cause nausea, sweating or autonomic changes.	Bowel obstruction, liver capsule stretch, pancreatic inflammation, urinary obstruction.
Neuropathic pain	Pain caused by a lesion or disease of the somatosensory nervous system.	Burning, electric, shooting, tingling, pins-and-needles, numbness, altered sensation, allodynia or sensory loss.	Diabetic neuropathy, post-herpetic neuralgia, nerve compression, spinal cord injury, chemotherapy neuropathy.
Nociplastic pain	Pain arising from altered nociception, without clear evidence of actual or threatened tissue damage sufficient to explain it and without a lesion or disease of the somatosensory system that explains it.	Widespread or regional pain, hypersensitivity, fatigue, poor sleep, cognitive symptoms and variable examination findings.	Fibromyalgia and some chronic primary pain presentations. It may coexist with other mechanisms.
Mixed-mechanism pain	Two or more mechanisms operating together or at different times.	For example, cancer-related bone pain plus nerve-root compression, or a surgical wound plus opioid-induced hyperalgesia.	Cancer pain, low-back pain, complex regional pain syndrome, postsurgical pain.

Important: these are mechanistic descriptors, not moral judgments and not rigid boxes. Mechanisms can coexist, change over time and be uncertain. A normal scan does not prove that pain is imaginary; an abnormal scan does not prove that it explains the pain.

5. Classification by anatomical source and distribution

• Superficial somatic pain: skin and mucosa; usually sharp, well localized and may cause withdrawal.
• Deep somatic pain: muscles, tendons, joints, fascia and bone; often aching and less precisely localized.
• Visceral pain: internal organs; commonly diffuse, poorly localized and associated with autonomic symptoms.
• Referred pain: perceived at a site distant from the source because visceral and somatic afferents converge on shared spinal neurons. Examples include diaphragmatic irritation felt in the shoulder and myocardial ischaemia felt in the arm or jaw.
• Radicular pain: pain following a nerve-root distribution, often shooting or electric, with possible sensory, reflex or motor changes.
• Peripheral neuropathic pain: from a peripheral nerve, plexus or root.
• Central pain: from a lesion or disease of the brain or spinal cord.
• Localized, regional or widespread pain: describe the map, symmetry and spread; a changing distribution may indicate progression, sensitization or a new diagnosis.

6. Classification by pattern, quality and severity

Descriptor	Examples	Why it matters
Continuous	Present most of the day with fluctuations.	Suggests an ongoing process; document baseline and peaks.
Intermittent	Comes and goes with periods of relief.	Ask about triggers, duration and what happens between attacks.
Colicky	Waves of cramping.	May reflect hollow-organ spasm or obstruction; assess for emergency causes.
Sharp/stabbing	Brief, pointed pain.	Can arise from skin, pleura, nerve or acute tissue injury.
Aching/throbbing	Deep or pulsating discomfort.	Common in inflammation, vascular and bone pain but not diagnostic alone.
Burning/electric/shooting	Abnormal sensory quality.	Raises suspicion of neuropathic involvement; examine sensation and strength.
Allodynia	Pain caused by a stimulus that is normally not painful, such as light touch.	Suggests altered sensory processing; handle gently and document distribution.
Hyperalgesia	Exaggerated pain from a normally painful stimulus.	May reflect peripheral or central sensitization.

Severity should be recorded using a validated tool appropriate to the patient: a 0–10 numerical rating scale, visual analogue scale, verbal descriptor scale, faces scale or an observational tool when self-report is impossible. A number alone is incomplete; record function, distress, location, quality, timing and the patient’s acceptable goal.

7. Physiology: from stimulus to experience

Pain physiology is often taught as four overlapping processes: transduction, transmission, perception and modulation. The biopsychosocial context influences every stage.

7.1 Transduction: converting a threat into a neural signal

Nociceptors are high-threshold sensory receptors, usually free nerve endings, that detect mechanical, thermal or chemical danger. Tissue injury releases or changes local mediators including potassium, hydrogen ions, ATP, bradykinin, histamine, serotonin, prostaglandins, leukotrienes, cytokines and nerve growth factor. These mediators alter ion channels on nociceptor terminals and produce a generator potential. If threshold is reached, voltage-gated sodium and calcium channels generate action potentials.

• Mechanical transduction: deformation, pressure, stretch or tissue disruption activates mechanosensitive channels.
• Thermal transduction: extreme heat or cold activates temperature-sensitive channels.
• Chemical transduction: inflammatory mediators and changes in pH activate or sensitize nociceptors.
• Peripheral sensitization: inflammatory mediators lower nociceptor threshold and increase response, causing primary hyperalgesia around injured tissue.

7.2 Transmission: carrying signals to the spinal cord and brain

Fibre	Myelination and speed	Typical contribution
A-delta fibres	Thinly myelinated and relatively fast.	First, sharp, pricking, well-localized pain and cold; helps trigger rapid withdrawal.
C fibres	Unmyelinated and slow.	Second, dull, burning, aching, poorly localized pain; often accompanied by autonomic and emotional responses.
A-beta fibres	Large, myelinated, fast touch/pressure fibres.	Usually non-nociceptive; activity can inhibit dorsal-horn transmission, but in sensitized states touch may become painful.

1. Primary afferent fibres enter the dorsal horn through the dorsal roots and may travel up or down a few spinal segments in Lissauer’s tract.
2. They synapse mainly in dorsal-horn laminae I, II and V. Glutamate mediates fast transmission; substance P and CGRP contribute to slower, sustained transmission.
3. Second-order neurons cross near the spinal entry level and ascend in the anterolateral/spinothalamic system.
4. Collateral pathways reach the brainstem reticular formation, midbrain and hypothalamus, contributing to arousal, autonomic responses and affect.

7.3 Perception: constructing pain in the brain

Perception is the conscious experience produced when the brain evaluates nociceptive input in context. It is not a passive read-out of tissue damage.

• Thalamus: relays and distributes sensory information to cortical and limbic regions.
• Primary and secondary somatosensory cortex: location, intensity, quality and body mapping.
• Insular cortex: internal body state and subjective unpleasantness.
• Anterior cingulate cortex: affective distress and motivational response.
• Prefrontal cortex: attention, expectation, interpretation, decision-making and appraisal.
• Amygdala and limbic networks: fear, threat learning and emotional salience.
• Brainstem and hypothalamus: arousal, autonomic and endocrine responses.

Attention, expectation, prior trauma, anxiety, sleep, culture, meaning and social safety can amplify or reduce the final experience. This does not make pain voluntary or “all in the mind.”

7.4 Modulation: amplification and inhibition

Signals are modified at the peripheral terminal, spinal dorsal horn, brainstem and higher centres.

• Spinal inhibition: inhibitory interneurons using GABA, glycine and endogenous opioids can reduce neurotransmitter release or hyperpolarize second-order neurons.
• Gate control: activity from large touch fibres can activate inhibitory dorsal-horn circuits, helping explain why rubbing a bumped area may briefly reduce pain. In disease, the gate can become facilitatory.
• Descending inhibition: cortex and limbic areas recruit the periaqueductal grey, rostroventral medulla and locus coeruleus. Serotonergic, noradrenergic and opioid systems can suppress transmission.
• Descending facilitation: the same networks can enhance pain, especially with threat, chronic stress, sleep loss and central sensitization.
• Endogenous opioids: endorphins, enkephalins and dynorphins act at opioid receptors and participate in analgesia, stress responses and reward.

8. Sensitization and abnormal pain processing

8.1 Peripheral sensitization

Inflammatory mediators increase nociceptor excitability and receptive fields. Normally non-painful heat or pressure may become painful near the injury. It generally decreases as inflammation resolves, but persistent inflammation can maintain it.

8.2 Central sensitization

Repeated or intense input increases excitability in the dorsal horn and higher networks. Glutamate acting at NMDA receptors, substance P, changes in inhibitory interneurons, altered descending control and glial signaling contribute. Clinically, the person may develop secondary hyperalgesia, allodynia, temporal summation (“wind-up”), pain spreading beyond the original injury and disproportionate responses.

8.3 Neuroimmune contributions

Microglia and astrocytes can release inflammatory mediators that alter synaptic transmission and maintain hypersensitivity. Sleep disturbance, stress hormones and reduced activity can reinforce this cycle. These mechanisms explain why the original tissue injury may heal while pain persists.

9. Gate-control and biopsychosocial models

The gate-control model emphasizes spinal modulation by touch, nociceptive input and descending brain signals. The biopsychosocial model expands this to include:

• Biological: tissue injury, inflammation, nerve lesion, genetics, sleep, comorbid disease and treatment effects.
• Psychological: attention, fear, anxiety, depression, trauma, beliefs, coping, expectation and perceived control.
• Social: family response, work, stigma, poverty, access to care, conflict, cultural meanings and safety.

These factors are not competing explanations. They interact continuously. A compassionate assessment therefore asks both “What is happening in the tissues?” and “What is happening in the person’s life and nervous system?”

10. Autonomic and emotional responses

Acute pain can activate sympathetic responses: tachycardia, hypertension, sweating, pallor, dilated pupils, nausea and vigilance. Severe or prolonged pain may instead be associated with fatigue, sleep disturbance, reduced appetite, depression, withdrawal, altered immune function and loss of function. In visceral pain, vagal responses such as nausea, bradycardia or faintness can occur. The absence of autonomic signs does not exclude severe pain, especially in older adults, people taking beta-blockers or those with chronic pain.

11. Pain in different patient groups

Children and neonates

Newborns and children feel pain. Immature communication and variable behaviour can mask it. Use age-appropriate self-report when possible, faces or observational tools when not, and combine behaviour with physiological and caregiver information. Repeated untreated pain can alter stress responses and pain processing.

Older adults

Do not assume that dementia, frailty or age eliminates pain. Ask directly, observe changes from baseline and use an observational tool if self-report is unavailable. Consider falls, arthritis, fractures, pressure injury, constipation, urinary retention, infection and medication effects.

People with communication disability

Use the person’s preferred communication method, involve a trusted supporter with permission and look for consistent changes in behaviour, movement, sleep and function. Treat inability to speak as a communication problem, not evidence of no pain.

People with substance-use history

Assess pain and safety without stigma. A history of substance use does not prove that current pain is fabricated, and prescribing a controlled medicine does not remove the need for monitoring, reconciliation and a clear plan.

12. Clinical bedside translation

Ask or observe	What it adds
Site and radiation	Maps anatomy, referred pain and nerve distributions; sudden migration may signal a changing emergency.
Onset and trigger	Distinguishes traumatic, exertional, procedure-related, spontaneous and incident patterns.
Quality	Burning/electric suggests neural involvement; cramping may suggest hollow-organ activity; quality is not diagnostic alone.
Intensity and interference	Records severity and effect on sleep, breathing, movement, eating, work, relationships and mood.
Timing	Separates continuous, episodic, breakthrough, end-of-dose and nocturnal patterns.
Associated symptoms	Fever, vomiting, weakness, numbness, bowel/bladder change, bleeding, dyspnoea, syncope or confusion may indicate a complication.
Examination	Inspect, palpate gently, assess range, sensation, strength, reflexes, perfusion, abdomen, spine and skin as clinically indicated.
Meaning and context	Reveals fear, trauma, social stress, spiritual distress, caregiver response and goals.

13. Pain-related emergencies not to miss

These warning signs require immediate clinical assessment. A palliative-care approach remains appropriate while the emergency is investigated and treated.

14. Common misconceptions

Myth	Correction
“If the scan is normal, the pain is not real.”	Imaging may miss neural, inflammatory, functional or early disease; pain is a clinical experience.
“A high pain score always means more tissue damage.”	Intensity reflects mechanisms and context, not tissue damage alone.
“Quiet patients are comfortable.”	Stoicism, fear, sedation, delirium, culture or communication barriers may hide pain.
“All palliative pain is cancer pain.”	Patients may also have infection, trauma, neuropathy, treatment toxicity, chronic disease and emergencies.
“Neuropathic, nociceptive and nociplastic are mutually exclusive.”	Mixed mechanisms are common and may change with time.
“Talking about pain makes it worse.”	Accurate assessment and compassionate communication usually improve safety and coping.

15. Clinical cases

16. Quick self-test

1. State the IASP definition of pain in your own words.
2. How does nociception differ from pain?
3. Compare nociceptive, neuropathic and nociplastic pain.
4. What are transduction, transmission, perception and modulation?
5. What is the difference between allodynia and hyperalgesia?
6. Name the major fibre types that carry or modulate pain-related signals.
7. Give four dimensions of total pain.
8. List five pain-related red flags requiring urgent assessment.

Answers

1. Pain is an unpleasant sensory and emotional experience associated with or resembling actual or potential tissue damage.
2. Nociception is neural detection and processing of potentially damaging stimuli; pain is the conscious, emotional experience constructed in context.
3. Nociceptive pain arises from non-neural tissue threat, neuropathic pain from a lesion or disease of the somatosensory system, and nociplastic pain from altered nociception not sufficiently explained by either tissue damage or a neural lesion. They can coexist.
4. Transduction converts a threat into neural activity; transmission carries it through peripheral nerves and spinal/ascending pathways; perception is the brain’s conscious experience; modulation amplifies or inhibits signals.
5. Allodynia is pain from a normally non-painful stimulus; hyperalgesia is exaggerated pain from a normally painful stimulus.
6. A-delta fibres carry fast, sharp signals; C fibres carry slow, burning/aching signals; A-beta touch fibres can activate inhibitory gating but may become painful in sensitization.
7. Physical, psychological, social and spiritual/existential.
8. Examples include sudden chest pain with shock, acute abdomen with guarding, new back pain with weakness/bladder change, limb pain with neurovascular compromise, severe headache with neurological deficit, fever with confusion, or suicidal/violent risk.

Key take-home points

• Pain is real, personal and multidimensional; it cannot be inferred from an image or facial expression alone.
• Always distinguish pain from nociception and describe both mechanism and lived impact.
• Nociceptive, neuropathic, nociplastic and mixed mechanisms may overlap and evolve.
• Transduction, transmission, perception and modulation explain why tissue injury, nervous-system sensitization and context all matter.
• In palliative care, assess total pain: physical, psychological, social and spiritual distress.
• A new pattern, neurological deficit, systemic instability or severe unexpected pain is an emergency until assessed.

Further study and references

• Pain in Palliative Care (supplied Slideshare reference)
• International Association for the Study of Pain: Terminology
• IASP curriculum outline on pain for medicine
• WHO guideline for pharmacological and radiotherapeutic management of cancer pain
• WHO: Palliative care
• NICE: Neuropathic pain in adults

Educational resource for supervised learning. Apply current Uganda Ministry of Health guidance, local protocols, formularies and senior clinical advice.